Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.
Teladoc Health reports news on its virtual care business, including financial results, segment performance, product innovation, technology investment, and governance updates. The company delivers and orchestrates care across patients, care providers, platforms, and partners through relationships with health plans, employers, providers, health systems, and consumers.
Recurring updates focus on Integrated Care, which includes virtual care solutions such as primary care, mental health, chronic care management, and telehealth enablement, and BetterHelp, the company’s direct-to-consumer online mental health offering. Company news also includes earnings calls, investor conference participation, board appointments and retirements, inducement equity awards, and strategic commentary on its clinical model and care-delivery platform.
Teladoc Health (TDOC) reported a significant growth in Q4 2020, with revenue soaring 145% year-over-year to $383.3 million and total visits rising 139% to 3.0 million. For the full year, revenue grew 98% to $1,094 million, with total visits increasing 156% to 10.6 million. Despite these gains, the net loss for Q4 was $(394.0 million), up from $(19.0 million) in Q4 2019, impacted by acquisition costs and stock-based compensation. Looking ahead, the company provided Q1 2021 revenue guidance of $445 million to $455 million.
Teladoc Health (NYSE: TDOC) announces participation in the Cowen Healthcare Conference on March 2, 2021, featuring CEO Jason Gorevic and CFO Mala Murthy at 12:50 p.m. ET. A live audio webcast and replay will be accessible on their investor relations website.
Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health is a leader in whole-person virtual care, utilizing proprietary health signals to enhance health outcomes. The company focuses on transforming the healthcare experience for improved consumer and professional engagement.
Teladoc Health, Inc. (NYSE: TDOC) is offering free, 24/7 telehealth visits to residents in Oklahoma and Texas affected by winter storms. Displaced individuals can access treatment for non-emergency illnesses by calling 855-225-5032. The initiative aims to enhance access to healthcare during electricity and heat loss due to extreme weather and the ongoing pandemic. Services include consultations for common conditions and COVID-19 screening. For more info, visit teladoc.com/disaster-hotline.
Teladoc Health (TDOC) will announce its fourth-quarter and full-year 2020 financial results on February 24, 2021, after market close. A conference call will follow at 4:30 p.m. E.T. for a detailed review of the results. Participants can join by phone or via a live audio webcast. Teladoc Health is recognized as a leader in whole-person virtual care, leveraging over a decade of insights and expertise to improve healthcare outcomes. For more details, visit the official website.
Teladoc Health released its inaugural Corporate Social Responsibility (CSR) Report, emphasizing its commitment to equitable healthcare access, responsibility, and community impact. In 2020, Teladoc provided over 10 million virtual visits, assisting over 2 million members in underserved areas. The report outlines efforts to enhance healthcare capacity during COVID-19, reduce CO2 emissions by 5,000 metric tons per million virtual visits, and promote a diverse workplace. Additionally, the company contributed $700,000 to global health initiatives.
Teladoc Health and DexCom announced a partnership to enhance diabetes management for Type 2 diabetes patients. Joint members of Livongo for Diabetes will receive new CGM-powered insights that integrate Dexcom’s continuous glucose monitoring data with additional health signals from Teladoc. This offering aims to empower users with actionable health recommendations and will be piloted at no cost to eligible members in 2021. The collaboration highlights a rising trend in diabetes, with estimates suggesting 463 million adults currently affected globally.
Teladoc Health, the leader in virtual care, announced participation in the 39th Annual J.P. Morgan Healthcare Conference by CEO Jason Gorevic and CFO Mala Murthy on January 11, 2021, at 10:00 a.m. ET. The event will include a live audio webcast accessible on the company's investor relations page. Teladoc Health focuses on enhancing healthcare experiences with a commitment to comprehensive virtual care, leveraging a decade of expertise to improve health outcomes. The company was recognized as Best in KLAS for Virtual Care Platforms in 2020.
World Telehealth Initiative (WTI) announced a new investment from Intel aimed at expanding healthcare access in developing communities through Teladoc Health's virtual care platform. Founded in 2017, WTI currently serves over 15 communities and plans to expand to 40 within two years. This investment will enable WTI to partner with more clinics, enhancing telehealth services during the COVID-19 pandemic. The initiative addresses the critical lack of healthcare services, with more than one billion people globally unable to access necessary health services.
Teladoc Health (NYSE: TDOC) announced its participation in two prominent investor conferences. The 29th Annual Credit Suisse Annual Healthcare Conference is scheduled for November 11 at 2:45 p.m. ET, and the 32nd Annual Piper Sandler Annual Healthcare Conference will take place on December 1 at 9:00 a.m. ET. A live audio webcast will be available for both events on their investor relations page. Teladoc Health continues to lead in virtual care, enhancing healthcare experiences globally.
Teladoc Health has finalized its merger with Livongo, creating a dominant force in whole-person virtual care. This strategic combination allows the company to offer comprehensive health solutions, serving consumers and healthcare providers through advanced analytics and technology. CEO Jason Gorevic emphasized the merger's potential to enhance health outcomes. Livongo shareholders will receive 0.5920x shares of Teladoc and $11.33 cash per share. The merger was completed in under three months, following the announcement on August 5.